

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | central nervous system myelination (GO:0022010) | 8.83422640 |
| 2 | axon ensheathment in central nervous system (GO:0032291) | 8.83422640 |
| 3 | regulation of B cell receptor signaling pathway (GO:0050855) | 6.90387541 |
| 4 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 6.33566839 |
| 5 | fatty acid elongation (GO:0030497) | 5.90137292 |
| 6 | response to methylmercury (GO:0051597) | 5.62435229 |
| 7 | B cell receptor signaling pathway (GO:0050853) | 5.45348066 |
| 8 | myelination (GO:0042552) | 5.29310768 |
| 9 | axon ensheathment (GO:0008366) | 5.25423223 |
| 10 | ensheathment of neurons (GO:0007272) | 5.25423223 |
| 11 | cytidine deamination (GO:0009972) | 5.02263088 |
| 12 | cytidine metabolic process (GO:0046087) | 5.02263088 |
| 13 | cytidine catabolic process (GO:0006216) | 5.02263088 |
| 14 | T cell lineage commitment (GO:0002360) | 4.82379901 |
| 15 | cholesterol biosynthetic process (GO:0006695) | 4.72111740 |
| 16 | leukocyte aggregation (GO:0070486) | 4.61895440 |
| 17 | long-chain fatty acid biosynthetic process (GO:0042759) | 4.59374687 |
| 18 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.52489865 |
| 19 | negative regulation of neurotransmitter secretion (GO:0046929) | 4.50888324 |
| 20 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 4.43575095 |
| 21 | B cell homeostasis (GO:0001782) | 4.43369413 |
| 22 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 4.35420590 |
| 23 | immunoglobulin mediated immune response (GO:0016064) | 4.35308583 |
| 24 | type I interferon signaling pathway (GO:0060337) | 4.34339329 |
| 25 | cellular response to type I interferon (GO:0071357) | 4.34339329 |
| 26 | response to type I interferon (GO:0034340) | 4.32798022 |
| 27 | interferon-gamma-mediated signaling pathway (GO:0060333) | 4.21210936 |
| 28 | regulation of collateral sprouting (GO:0048670) | 4.20642081 |
| 29 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 4.15684362 |
| 30 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.15586161 |
| 31 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.15586161 |
| 32 | modulation by symbiont of host immune response (GO:0052553) | 4.15586161 |
| 33 | positive regulation by symbiont of host defense response (GO:0052509) | 4.15586161 |
| 34 | modulation by symbiont of host defense response (GO:0052031) | 4.15586161 |
| 35 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.15586161 |
| 36 | negative regulation of B cell proliferation (GO:0030889) | 4.09268862 |
| 37 | negative T cell selection (GO:0043383) | 4.08977834 |
| 38 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 4.08327968 |
| 39 | response to interleukin-15 (GO:0070672) | 4.06169204 |
| 40 | B cell mediated immunity (GO:0019724) | 4.06061606 |
| 41 | sterol biosynthetic process (GO:0016126) | 4.05911507 |
| 42 | positive regulation of humoral immune response (GO:0002922) | 4.04856735 |
| 43 | regulation of isotype switching to IgG isotypes (GO:0048302) | 4.02701176 |
| 44 | positive regulation of B cell differentiation (GO:0045579) | 4.01852415 |
| 45 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.00981737 |
| 46 | negative regulation of cell killing (GO:0031342) | 4.00981737 |
| 47 | response to redox state (GO:0051775) | 4.00207006 |
| 48 | negative thymic T cell selection (GO:0045060) | 3.99284398 |
| 49 | Rap protein signal transduction (GO:0032486) | 3.99002899 |
| 50 | positive regulation of T cell cytokine production (GO:0002726) | 3.97152983 |
| 51 | negative regulation of neurotransmitter transport (GO:0051589) | 3.96148647 |
| 52 | cellular response to interleukin-15 (GO:0071350) | 3.93942317 |
| 53 | activated T cell proliferation (GO:0050798) | 3.89797503 |
| 54 | eye photoreceptor cell differentiation (GO:0001754) | 3.89301578 |
| 55 | photoreceptor cell differentiation (GO:0046530) | 3.89301578 |
| 56 | nerve growth factor signaling pathway (GO:0038180) | 3.88101578 |
| 57 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.86312891 |
| 58 | amyloid precursor protein metabolic process (GO:0042982) | 3.84826209 |
| 59 | myeloid dendritic cell activation (GO:0001773) | 3.84275886 |
| 60 | B cell proliferation (GO:0042100) | 3.80888905 |
| 61 | response to lipoprotein particle (GO:0055094) | 3.80601631 |
| 62 | positive regulation of Rap GTPase activity (GO:0032854) | 3.79150386 |
| 63 | regulation of B cell differentiation (GO:0045577) | 3.78542732 |
| 64 | regulation of T cell tolerance induction (GO:0002664) | 3.75423516 |
| 65 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.75046771 |
| 66 | myeloid dendritic cell differentiation (GO:0043011) | 3.74808184 |
| 67 | NIK/NF-kappaB signaling (GO:0038061) | 3.73069064 |
| 68 | regulation of cytokine production involved in inflammatory response (GO:1900015) | 3.71863113 |
| 69 | Sertoli cell development (GO:0060009) | 3.65441959 |
| 70 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.65372399 |
| 71 | astrocyte development (GO:0014002) | 3.60923982 |
| 72 | cellular response to electrical stimulus (GO:0071257) | 3.60353764 |
| 73 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.58251412 |
| 74 | creatine metabolic process (GO:0006600) | 3.57436332 |
| 75 | tolerance induction (GO:0002507) | 3.56533890 |
| 76 | peripheral nervous system axon ensheathment (GO:0032292) | 3.55384996 |
| 77 | myelination in peripheral nervous system (GO:0022011) | 3.55384996 |
| 78 | mast cell activation (GO:0045576) | 3.54422797 |
| 79 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 3.50022823 |
| 80 | positive regulation of interferon-alpha production (GO:0032727) | 3.40503595 |
| 81 | regulation of B cell proliferation (GO:0030888) | 3.37518339 |
| 82 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.37431076 |
| 83 | T-helper 1 type immune response (GO:0042088) | 3.35320380 |
| 84 | L-amino acid import (GO:0043092) | 3.33429604 |
| 85 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.32011011 |
| 86 | myelin maintenance (GO:0043217) | 3.31880186 |
| 87 | regulation of interleukin-13 production (GO:0032656) | 3.31849097 |
| 88 | cellular response to interferon-gamma (GO:0071346) | 3.30755783 |
| 89 | DNA deamination (GO:0045006) | 3.29953658 |
| 90 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.29585043 |
| 91 | mast cell degranulation (GO:0043303) | 3.27645134 |
| 92 | mast cell activation involved in immune response (GO:0002279) | 3.27645134 |
| 93 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 3.25025811 |
| 94 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.24855630 |
| 95 | neuronal action potential propagation (GO:0019227) | 3.24584067 |
| 96 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 3.21605784 |
| 97 | regulation of Rap GTPase activity (GO:0032317) | 3.20627420 |
| 98 | interferon-gamma production (GO:0032609) | 3.20479458 |
| 99 | regulation of interferon-alpha production (GO:0032647) | 3.17864092 |
| 100 | nucleoside diphosphate catabolic process (GO:0009134) | 3.12479678 |
| 101 | oligodendrocyte differentiation (GO:0048709) | 3.11888078 |
| 102 | regulation of interferon-gamma biosynthetic process (GO:0045072) | 3.11660955 |
| 103 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 3.09607902 |
| 104 | * T cell migration (GO:0072678) | 3.09488695 |
| 105 | positive regulation of macrophage cytokine production (GO:0060907) | 3.08722049 |
| 106 | protein palmitoylation (GO:0018345) | 3.08538186 |
| 107 | detection of bacterium (GO:0016045) | 3.06870657 |
| 108 | lymphocyte costimulation (GO:0031294) | 3.05757186 |
| 109 | regulation of T cell cytokine production (GO:0002724) | 3.04981069 |
| 110 | positive regulation of interleukin-4 production (GO:0032753) | 3.03629504 |
| 111 | positive T cell selection (GO:0043368) | 3.03585131 |
| 112 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 3.02289636 |
| 113 | positive regulation of interleukin-2 production (GO:0032743) | 3.01482931 |
| 114 | mature B cell differentiation (GO:0002335) | 3.00529590 |
| 115 | positive regulation of cytokine biosynthetic process (GO:0042108) | 2.99664729 |
| 116 | lymphocyte homeostasis (GO:0002260) | 2.98612643 |
| 117 | positive regulation of cell fate commitment (GO:0010455) | 2.97497581 |
| 118 | thymic T cell selection (GO:0045061) | 2.96865654 |
| 119 | response to host immune response (GO:0052572) | 2.96676203 |
| 120 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.96676203 |
| 121 | T cell costimulation (GO:0031295) | 2.96443460 |
| 122 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.96186881 |
| 123 | negative regulation of viral genome replication (GO:0045071) | 2.95454020 |
| 124 | substantia nigra development (GO:0021762) | 2.93019371 |
| 125 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.92918188 |
| 126 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.92201744 |
| 127 | positive regulation of B cell mediated immunity (GO:0002714) | 2.92201744 |
| 128 | amyloid precursor protein catabolic process (GO:0042987) | 2.92052055 |
| 129 | isoprenoid biosynthetic process (GO:0008299) | 2.91158617 |
| 130 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 2.87753325 |
| 131 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.87165606 |
| 132 | T cell receptor signaling pathway (GO:0050852) | 2.87117644 |
| 133 | response to protozoan (GO:0001562) | 2.86130720 |
| 134 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 2.85600785 |
| 135 | defense response to protozoan (GO:0042832) | 2.84888762 |
| 136 | T cell selection (GO:0045058) | 2.82417769 |
| 137 | establishment of mitochondrion localization (GO:0051654) | 2.82233150 |
| 138 | adaptive immune response based on somatic recombination of immune receptors built from immunoglobuli | 2.81675796 |
| 139 | regulation of gamma-delta T cell activation (GO:0046643) | 2.81239631 |
| 140 | positive regulation of interleukin-12 production (GO:0032735) | 2.80262831 |
| 141 | regulation of B cell activation (GO:0050864) | 2.80174570 |
| 142 | negative regulation of interleukin-10 production (GO:0032693) | 2.79893632 |
| 143 | response to interferon-gamma (GO:0034341) | 2.79611172 |
| 144 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.79500273 |
| 145 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.78663007 |
| 146 | positive regulation of interleukin-17 production (GO:0032740) | 2.78546424 |
| 147 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 2.78111199 |
| 148 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 2.78111199 |
| 149 | detection of other organism (GO:0098543) | 2.77604759 |
| 150 | organ growth (GO:0035265) | 2.76104332 |
| 151 | positive regulation of B cell proliferation (GO:0030890) | 2.75530678 |
| 152 | positive regulation of tolerance induction (GO:0002645) | 2.75439298 |
| 153 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.74380087 |
| 154 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.74380087 |
| 155 | regulation of antigen processing and presentation (GO:0002577) | 2.72956728 |
| 156 | semaphorin-plexin signaling pathway (GO:0071526) | 2.72536586 |
| 157 | adhesion of symbiont to host cell (GO:0044650) | 2.72164024 |
| 158 | virion attachment to host cell (GO:0019062) | 2.72164024 |
| 159 | regulation of chronic inflammatory response (GO:0002676) | 2.72071548 |
| 160 | negative regulation of execution phase of apoptosis (GO:1900118) | 2.71401926 |
| 161 | negative regulation of axonogenesis (GO:0050771) | 2.71344258 |
| 162 | positive regulation of B cell activation (GO:0050871) | 2.69576722 |
| 163 | fatty-acyl-CoA metabolic process (GO:0035337) | 2.69330948 |
| 164 | regulation of lipoprotein metabolic process (GO:0050746) | 2.68670630 |
| 165 | response to host (GO:0075136) | 2.68622085 |
| 166 | response to host defenses (GO:0052200) | 2.68622085 |
| 167 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.68622085 |
| 168 | regulation of alpha-beta T cell activation (GO:0046634) | 2.68502219 |
| 169 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.67009853 |
| 170 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.67009853 |
| 171 | membrane protein ectodomain proteolysis (GO:0006509) | 2.63434937 |
| 172 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 2.63059865 |
| 173 | positive thymic T cell selection (GO:0045059) | 2.62385237 |
| 174 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 2.60536614 |
| 175 | regulation of ARF GTPase activity (GO:0032312) | 2.59866280 |
| 176 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.58692607 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 6.17632554 |
| 2 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 5.05563184 |
| 3 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 4.12820985 |
| 4 | MYC_22102868_ChIP-Seq_BL_Human | 3.90086305 |
| 5 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 3.47574820 |
| 6 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.44437562 |
| 7 | RUNX_20019798_ChIP-Seq_JUKART_Human | 3.38439443 |
| 8 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.04091812 |
| 9 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.99995094 |
| 10 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.99469999 |
| 11 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.97494571 |
| 12 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.82892453 |
| 13 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.67336688 |
| 14 | GATA1_22025678_ChIP-Seq_K562_Human | 2.66296277 |
| 15 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 2.59163429 |
| 16 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.58029991 |
| 17 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.57246397 |
| 18 | CIITA_25753668_ChIP-Seq_RAJI_Human | 2.43453875 |
| 19 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.32596630 |
| 20 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 2.24213851 |
| 21 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.19890991 |
| 22 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.16179271 |
| 23 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.13912379 |
| 24 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.08720489 |
| 25 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.07814027 |
| 26 | MYB_26560356_Chip-Seq_TH2_Human | 2.00034652 |
| 27 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.93539373 |
| 28 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.92762293 |
| 29 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.92416785 |
| 30 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.83959491 |
| 31 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.82367775 |
| 32 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.80119173 |
| 33 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.79235170 |
| 34 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.74104642 |
| 35 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.71398937 |
| 36 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.70916142 |
| 37 | VDR_22108803_ChIP-Seq_LS180_Human | 1.70658311 |
| 38 | MAF_26560356_Chip-Seq_TH1_Human | 1.70568463 |
| 39 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.70532321 |
| 40 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.66294054 |
| 41 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.62030851 |
| 42 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.60047445 |
| 43 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.59208474 |
| 44 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.59094015 |
| 45 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.53768946 |
| 46 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.51824548 |
| 47 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.51540317 |
| 48 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.51345032 |
| 49 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.51014358 |
| 50 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.50857778 |
| 51 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.50377256 |
| 52 | MYB_26560356_Chip-Seq_TH1_Human | 1.49886485 |
| 53 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.49407266 |
| 54 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.48333824 |
| 55 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.46045131 |
| 56 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.43923187 |
| 57 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.43494674 |
| 58 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.41935712 |
| 59 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.41146467 |
| 60 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.40764157 |
| 61 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.40059147 |
| 62 | MAF_26560356_Chip-Seq_TH2_Human | 1.39658250 |
| 63 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.39598226 |
| 64 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.38266447 |
| 65 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.31802480 |
| 66 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.30877468 |
| 67 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.29504819 |
| 68 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.27967338 |
| 69 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.27717354 |
| 70 | SPI1_23127762_ChIP-Seq_K562_Human | 1.26648588 |
| 71 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.26127847 |
| 72 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.25162404 |
| 73 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.21998628 |
| 74 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.21197485 |
| 75 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.20892840 |
| 76 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.20259726 |
| 77 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.19161726 |
| 78 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.19150007 |
| 79 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.17887669 |
| 80 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.17677790 |
| 81 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.17649526 |
| 82 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.17458175 |
| 83 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.16477774 |
| 84 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.16370590 |
| 85 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.16279767 |
| 86 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.14928281 |
| 87 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.13254564 |
| 88 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.12956643 |
| 89 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.12788386 |
| 90 | UTX_26944678_Chip-Seq_JUKART_Human | 1.11791448 |
| 91 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.10567230 |
| 92 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.09992502 |
| 93 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.09854631 |
| 94 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.09135211 |
| 95 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.06058173 |
| 96 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.05186724 |
| 97 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.05153522 |
| 98 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.04970175 |
| 99 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.04641071 |
| 100 | TP53_16413492_ChIP-PET_HCT116_Human | 1.04200881 |
| 101 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.03676469 |
| 102 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.03389622 |
| 103 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.02640719 |
| 104 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.01984541 |
| 105 | GATA1_19941826_ChIP-Seq_K562_Human | 1.01723350 |
| 106 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.01138395 |
| 107 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.00126950 |
| 108 | SPI1_23547873_ChIP-Seq_NB4_Human | 0.99669305 |
| 109 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.98679851 |
| 110 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.98065813 |
| 111 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.97983123 |
| 112 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.97409443 |
| 113 | GF1_26923725_Chip-Seq_HPCs_Mouse | 0.97154070 |
| 114 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.94233346 |
| 115 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.94021455 |
| 116 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.93280157 |
| 117 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.92313829 |
| 118 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 0.91660601 |
| 119 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.91379925 |
| 120 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.90619063 |
| 121 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.90549144 |
| 122 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.90051402 |
| 123 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.89908091 |
| 124 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.89832805 |
| 125 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.89485240 |
| 126 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.88509924 |
| 127 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 0.88081770 |
| 128 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 0.88018543 |
| 129 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.87934199 |
| 130 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.87603819 |
| 131 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 0.87384929 |
| 132 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.87167852 |
| 133 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 0.86817875 |
| 134 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 0.86529362 |
| 135 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.86432742 |
| 136 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.86263389 |
| 137 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.85173733 |
| 138 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.84893014 |
| 139 | TCF4_23295773_ChIP-Seq_U87_Human | 0.84872735 |
| 140 | GATA2_19941826_ChIP-Seq_K562_Human | 0.84347907 |
| 141 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 0.84081042 |
| 142 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.84016186 |
| 143 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.83489631 |
| 144 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.83266569 |
| 145 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.83147346 |
| 146 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.83006285 |
| 147 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 0.82247107 |
| 148 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.82086845 |
| 149 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.81794909 |
| 150 | EZH2_22144423_ChIP-Seq_EOC_Human | 0.81690748 |
| 151 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.81438172 |
| 152 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.81054671 |
| 153 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.80837721 |
| 154 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.78124366 |
| 155 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.77966590 |
| 156 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.76849612 |
| 157 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.76608254 |
| 158 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 0.75195105 |
| 159 | CBP_21632823_ChIP-Seq_H3396_Human | 0.74381953 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000920_abnormal_myelination | 4.44933461 |
| 2 | MP0002166_altered_tumor_susceptibility | 3.77179300 |
| 3 | MP0004381_abnormal_hair_follicle | 3.24080503 |
| 4 | MP0003300_gastrointestinal_ulcer | 2.93957845 |
| 5 | MP0003690_abnormal_glial_cell | 2.86525866 |
| 6 | MP0002006_tumorigenesis | 2.86247603 |
| 7 | MP0003763_abnormal_thymus_physiology | 2.73014097 |
| 8 | MP0008057_abnormal_DNA_replication | 2.70954815 |
| 9 | MP0003329_amyloid_beta_deposits | 2.58942706 |
| 10 | MP0005671_abnormal_response_to | 2.57340431 |
| 11 | MP0004742_abnormal_vestibular_system | 2.45087553 |
| 12 | MP0005387_immune_system_phenotype | 2.24893974 |
| 13 | MP0001790_abnormal_immune_system | 2.24893974 |
| 14 | MP0003045_fibrosis | 2.24824263 |
| 15 | MP0005410_abnormal_fertilization | 2.23168476 |
| 16 | MP0005645_abnormal_hypothalamus_physiol | 2.21772550 |
| 17 | MP0002822_catalepsy | 2.18911191 |
| 18 | MP0005000_abnormal_immune_tolerance | 2.16156815 |
| 19 | MP0002138_abnormal_hepatobiliary_system | 2.13965293 |
| 20 | MP0010094_abnormal_chromosome_stability | 2.12451983 |
| 21 | MP0003656_abnormal_erythrocyte_physiolo | 2.09120628 |
| 22 | MP0003950_abnormal_plasma_membrane | 2.09022555 |
| 23 | MP0001800_abnormal_humoral_immune | 2.06628910 |
| 24 | MP0002933_joint_inflammation | 2.02665136 |
| 25 | MP0002163_abnormal_gland_morphology | 2.01977611 |
| 26 | MP0001905_abnormal_dopamine_level | 1.96397923 |
| 27 | MP0000685_abnormal_immune_system | 1.94030478 |
| 28 | MP0001348_abnormal_lacrimal_gland | 1.90531743 |
| 29 | MP0002723_abnormal_immune_serum | 1.84717429 |
| 30 | MP0003136_yellow_coat_color | 1.83943896 |
| 31 | MP0001835_abnormal_antigen_presentation | 1.82181602 |
| 32 | MP0000604_amyloidosis | 1.81653059 |
| 33 | MP0002420_abnormal_adaptive_immunity | 1.79890450 |
| 34 | MP0003866_abnormal_defecation | 1.79251425 |
| 35 | MP0002148_abnormal_hypersensitivity_rea | 1.78818181 |
| 36 | MP0003880_abnormal_central_pattern | 1.77531986 |
| 37 | MP0001986_abnormal_taste_sensitivity | 1.76496162 |
| 38 | MP0001819_abnormal_immune_cell | 1.74877914 |
| 39 | MP0003303_peritoneal_inflammation | 1.70875691 |
| 40 | MP0003172_abnormal_lysosome_physiology | 1.70862414 |
| 41 | MP0005025_abnormal_response_to | 1.68881483 |
| 42 | MP0003632_abnormal_nervous_system | 1.68372486 |
| 43 | MP0002452_abnormal_antigen_presenting | 1.65952638 |
| 44 | MP0003634_abnormal_glial_cell | 1.65635178 |
| 45 | MP0003436_decreased_susceptibility_to | 1.65469935 |
| 46 | MP0009333_abnormal_splenocyte_physiolog | 1.63487573 |
| 47 | MP0001485_abnormal_pinna_reflex | 1.59854714 |
| 48 | MP0003693_abnormal_embryo_hatching | 1.59850432 |
| 49 | MP0009785_altered_susceptibility_to | 1.59744019 |
| 50 | MP0002272_abnormal_nervous_system | 1.59322854 |
| 51 | MP0006082_CNS_inflammation | 1.58134183 |
| 52 | MP0002419_abnormal_innate_immunity | 1.57062576 |
| 53 | MP0000465_gastrointestinal_hemorrhage | 1.56052449 |
| 54 | MP0003724_increased_susceptibility_to | 1.52908717 |
| 55 | MP0003111_abnormal_nucleus_morphology | 1.46725884 |
| 56 | MP0002398_abnormal_bone_marrow | 1.45120888 |
| 57 | MP0000716_abnormal_immune_system | 1.44629994 |
| 58 | MP0001486_abnormal_startle_reflex | 1.43293110 |
| 59 | MP0005310_abnormal_salivary_gland | 1.41871458 |
| 60 | MP0010155_abnormal_intestine_physiology | 1.40567906 |
| 61 | MP0003077_abnormal_cell_cycle | 1.39882604 |
| 62 | MP0004885_abnormal_endolymph | 1.38848765 |
| 63 | MP0001529_abnormal_vocalization | 1.37387684 |
| 64 | MP0004270_analgesia | 1.33721687 |
| 65 | MP0004134_abnormal_chest_morphology | 1.33594790 |
| 66 | MP0008260_abnormal_autophagy | 1.27696278 |
| 67 | MP0002229_neurodegeneration | 1.27225115 |
| 68 | MP0001851_eye_inflammation | 1.25032190 |
| 69 | MP0002019_abnormal_tumor_incidence | 1.23466241 |
| 70 | MP0003631_nervous_system_phenotype | 1.22806919 |
| 71 | MP0005058_abnormal_lysosome_morphology | 1.16772374 |
| 72 | MP0009745_abnormal_behavioral_response | 1.16470021 |
| 73 | MP0005623_abnormal_meninges_morphology | 1.15622711 |
| 74 | MP0004036_abnormal_muscle_relaxation | 1.14454255 |
| 75 | MP0000689_abnormal_spleen_morphology | 1.14429107 |
| 76 | MP0002405_respiratory_system_inflammati | 1.14302315 |
| 77 | MP0005464_abnormal_platelet_physiology | 1.13453668 |
| 78 | MP0005451_abnormal_body_composition | 1.13431874 |
| 79 | MP0002009_preneoplasia | 1.10525715 |
| 80 | MP0003183_abnormal_peptide_metabolism | 1.08836191 |
| 81 | MP0005075_abnormal_melanosome_morpholog | 1.08740575 |
| 82 | MP0005379_endocrine/exocrine_gland_phen | 1.08287226 |
| 83 | MP0000372_irregular_coat_pigmentation | 1.07028314 |
| 84 | MP0002064_seizures | 1.05658891 |
| 85 | MP0002396_abnormal_hematopoietic_system | 1.05424255 |
| 86 | MP0000778_abnormal_nervous_system | 1.05214547 |
| 87 | MP0002722_abnormal_immune_system | 1.05036367 |
| 88 | MP0002429_abnormal_blood_cell | 1.03587662 |
| 89 | MP0003633_abnormal_nervous_system | 1.03394445 |
| 90 | MP0003195_calcinosis | 1.02328443 |
| 91 | MP0002234_abnormal_pharynx_morphology | 1.01517459 |
| 92 | MP0008874_decreased_physiological_sensi | 1.00073245 |
| 93 | MP0004185_abnormal_adipocyte_glucose | 0.99229633 |
| 94 | MP0004859_abnormal_synaptic_plasticity | 0.98029715 |
| 95 | MP0004145_abnormal_muscle_electrophysio | 0.94013431 |
| 96 | MP0000703_abnormal_thymus_morphology | 0.93885874 |
| 97 | MP0005174_abnormal_tail_pigmentation | 0.93160146 |
| 98 | MP0004808_abnormal_hematopoietic_stem | 0.91285000 |
| 99 | MP0010678_abnormal_skin_adnexa | 0.89783586 |
| 100 | MP0004957_abnormal_blastocyst_morpholog | 0.88902212 |
| 101 | MP0008469_abnormal_protein_level | 0.86890478 |
| 102 | MP0001873_stomach_inflammation | 0.86634859 |
| 103 | MP0003075_altered_response_to | 0.85757154 |
| 104 | MP0001845_abnormal_inflammatory_respons | 0.85530503 |
| 105 | MP0003453_abnormal_keratinocyte_physiol | 0.85237824 |
| 106 | MP0000383_abnormal_hair_follicle | 0.85127581 |
| 107 | MP0000350_abnormal_cell_proliferation | 0.83163256 |
| 108 | MP0003635_abnormal_synaptic_transmissio | 0.82723802 |
| 109 | MP0000490_abnormal_crypts_of | 0.82132902 |
| 110 | MP0002928_abnormal_bile_duct | 0.82101986 |
| 111 | MP0003959_abnormal_lean_body | 0.82026782 |
| 112 | MP0004924_abnormal_behavior | 0.81542175 |
| 113 | MP0005386_behavior/neurological_phenoty | 0.81542175 |
| 114 | MP0010307_abnormal_tumor_latency | 0.81286910 |
| 115 | MP0003252_abnormal_bile_duct | 0.80846992 |
| 116 | MP0004142_abnormal_muscle_tone | 0.80340139 |
| 117 | MP0001533_abnormal_skeleton_physiology | 0.79560966 |
| 118 | MP0006035_abnormal_mitochondrial_morpho | 0.78730378 |
| 119 | MP0004947_skin_inflammation | 0.77640455 |
| 120 | MP0000747_muscle_weakness | 0.77271117 |
| 121 | MP0002693_abnormal_pancreas_physiology | 0.77199113 |
| 122 | MP0010234_abnormal_vibrissa_follicle | 0.77008100 |
| 123 | MP0000313_abnormal_cell_death | 0.76829045 |
| 124 | MP0008058_abnormal_DNA_repair | 0.76243794 |
| 125 | MP0001853_heart_inflammation | 0.75947795 |
| 126 | MP0005220_abnormal_exocrine_pancreas | 0.75397709 |
| 127 | MP0002998_abnormal_bone_remodeling | 0.75095250 |
| 128 | MP0001299_abnormal_eye_distance/ | 0.73677140 |
| 129 | MP0001346_abnormal_lacrimal_gland | 0.73315374 |
| 130 | MP0003091_abnormal_cell_migration | 0.73015686 |
| 131 | MP0002572_abnormal_emotion/affect_behav | 0.72730356 |
| 132 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.72471680 |
| 133 | MP0000858_altered_metastatic_potential | 0.72447137 |
| 134 | MP0000427_abnormal_hair_cycle | 0.69620659 |
| 135 | MP0003448_altered_tumor_morphology | 0.68908664 |
| 136 | MP0008569_lethality_at_weaning | 0.68314471 |
| 137 | MP0009763_increased_sensitivity_to | 0.63344920 |
| 138 | MP0008872_abnormal_physiological_respon | 0.61479651 |
| 139 | MP0003221_abnormal_cardiomyocyte_apopto | 0.60038530 |
| 140 | MP0003868_abnormal_feces_composition | 0.59475378 |
| 141 | MP0008007_abnormal_cellular_replicative | 0.58871817 |
| 142 | MP0002139_abnormal_hepatobiliary_system | 0.57560092 |
| 143 | MP0003786_premature_aging | 0.56752929 |
| 144 | MP0002136_abnormal_kidney_physiology | 0.55953668 |
| 145 | MP0002168_other_aberrant_phenotype | 0.54369635 |
| 146 | MP0000371_diluted_coat_color | 0.53604382 |
| 147 | MP0008961_abnormal_basal_metabolism | 0.52760791 |
| 148 | MP0000609_abnormal_liver_physiology | 0.52754149 |
| 149 | MP0005621_abnormal_cell_physiology | 0.51433122 |
| 150 | MP0001727_abnormal_embryo_implantation | 0.49182948 |
| 151 | MP0005166_decreased_susceptibility_to | 0.47324278 |
| 152 | MP0000015_abnormal_ear_pigmentation | 0.46148594 |
| 153 | MP0002083_premature_death | 0.41058120 |
| 154 | MP0000249_abnormal_blood_vessel | 0.40307987 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Agammaglobulinemia (HP:0004432) | 6.37348692 |
| 2 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 6.09570577 |
| 3 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 6.09570577 |
| 4 | Neurofibrillary tangles (HP:0002185) | 4.80591314 |
| 5 | Lymphopenia (HP:0001888) | 4.68075304 |
| 6 | Onion bulb formation (HP:0003383) | 4.64117111 |
| 7 | IgG deficiency (HP:0004315) | 4.58654872 |
| 8 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 4.58450660 |
| 9 | Colitis (HP:0002583) | 4.44638887 |
| 10 | Abnormality of the corticospinal tract (HP:0002492) | 4.26134932 |
| 11 | Mediastinal lymphadenopathy (HP:0100721) | 4.12352818 |
| 12 | Sensory axonal neuropathy (HP:0003390) | 3.94304483 |
| 13 | Cerebral inclusion bodies (HP:0100314) | 3.83597468 |
| 14 | Peripheral hypomyelination (HP:0007182) | 3.78828585 |
| 15 | Chronic otitis media (HP:0000389) | 3.77230915 |
| 16 | Emphysema (HP:0002097) | 3.74864138 |
| 17 | Spastic gait (HP:0002064) | 3.72723324 |
| 18 | Autoimmune hemolytic anemia (HP:0001890) | 3.72513015 |
| 19 | Cerebral hypomyelination (HP:0006808) | 3.68498688 |
| 20 | Cellulitis (HP:0100658) | 3.65308736 |
| 21 | Absent hand (HP:0004050) | 3.53404616 |
| 22 | T lymphocytopenia (HP:0005403) | 3.40260353 |
| 23 | Parakeratosis (HP:0001036) | 3.39952149 |
| 24 | Recurrent lower respiratory tract infections (HP:0002783) | 3.31651425 |
| 25 | B lymphocytopenia (HP:0010976) | 3.27779647 |
| 26 | Abnormality of T cell number (HP:0011839) | 3.22650890 |
| 27 | Lymphoma (HP:0002665) | 3.21010805 |
| 28 | Verrucae (HP:0200043) | 3.19405490 |
| 29 | Papilloma (HP:0012740) | 3.19405490 |
| 30 | Recurrent pneumonia (HP:0006532) | 3.13206142 |
| 31 | Stomatitis (HP:0010280) | 3.12439023 |
| 32 | Increased IgM level (HP:0003496) | 3.08516461 |
| 33 | Persistence of primary teeth (HP:0006335) | 3.03206143 |
| 34 | Osteomyelitis (HP:0002754) | 3.00051021 |
| 35 | Distal lower limb amyotrophy (HP:0008944) | 2.99677813 |
| 36 | Abnormality of B cell number (HP:0010975) | 2.99509429 |
| 37 | Recurrent bronchitis (HP:0002837) | 2.92574189 |
| 38 | Recurrent bacterial skin infections (HP:0005406) | 2.92184209 |
| 39 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.89784801 |
| 40 | Bronchitis (HP:0012387) | 2.89645804 |
| 41 | Cerebral hemorrhage (HP:0001342) | 2.88071452 |
| 42 | Relative macrocephaly (HP:0004482) | 2.87882369 |
| 43 | Viral hepatitis (HP:0006562) | 2.86687871 |
| 44 | Basal cell carcinoma (HP:0002671) | 2.86635384 |
| 45 | Abnormality of the prostate (HP:0008775) | 2.81980370 |
| 46 | Termporal pattern (HP:0011008) | 2.81742803 |
| 47 | Insidious onset (HP:0003587) | 2.81742803 |
| 48 | Hepatosplenomegaly (HP:0001433) | 2.81609513 |
| 49 | Axonal loss (HP:0003447) | 2.80621502 |
| 50 | Supranuclear gaze palsy (HP:0000605) | 2.77587874 |
| 51 | IgM deficiency (HP:0002850) | 2.76281176 |
| 52 | Recurrent sinusitis (HP:0011108) | 2.75958087 |
| 53 | Premature loss of primary teeth (HP:0006323) | 2.75879901 |
| 54 | Squamous cell carcinoma (HP:0002860) | 2.75050213 |
| 55 | Chin dimple (HP:0010751) | 2.73659506 |
| 56 | Panhypogammaglobulinemia (HP:0003139) | 2.72917727 |
| 57 | Recurrent abscess formation (HP:0002722) | 2.72318593 |
| 58 | Recurrent skin infections (HP:0001581) | 2.65734764 |
| 59 | Scanning speech (HP:0002168) | 2.62459957 |
| 60 | Recurrent cutaneous fungal infections (HP:0011370) | 2.62111761 |
| 61 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.62111761 |
| 62 | Urticaria (HP:0001025) | 2.59255185 |
| 63 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.56074932 |
| 64 | Inflammation of the large intestine (HP:0002037) | 2.55054436 |
| 65 | Leukopenia (HP:0001882) | 2.54607883 |
| 66 | Slow saccadic eye movements (HP:0000514) | 2.54514540 |
| 67 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.53547553 |
| 68 | Stridor (HP:0010307) | 2.51817058 |
| 69 | Intention tremor (HP:0002080) | 2.51035890 |
| 70 | Recurrent viral infections (HP:0004429) | 2.48426492 |
| 71 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.46456089 |
| 72 | IgA deficiency (HP:0002720) | 2.46256116 |
| 73 | Lower limb amyotrophy (HP:0007210) | 2.45043000 |
| 74 | Abnormality of T cells (HP:0002843) | 2.44880940 |
| 75 | Gastrointestinal infarctions (HP:0005244) | 2.42489382 |
| 76 | Recurrent fungal infections (HP:0002841) | 2.40336190 |
| 77 | Poikiloderma (HP:0001029) | 2.37860311 |
| 78 | Septate vagina (HP:0001153) | 2.37596615 |
| 79 | Ankle clonus (HP:0011448) | 2.36988641 |
| 80 | Chronic obstructive pulmonary disease (HP:0006510) | 2.35969664 |
| 81 | Obstructive lung disease (HP:0006536) | 2.35969664 |
| 82 | Eczematoid dermatitis (HP:0000976) | 2.35959459 |
| 83 | Loss of speech (HP:0002371) | 2.35502718 |
| 84 | Skin rash (HP:0000988) | 2.34567734 |
| 85 | Optic neuritis (HP:0100653) | 2.33092539 |
| 86 | Retrobulbar optic neuritis (HP:0100654) | 2.33092539 |
| 87 | Gastrointestinal stroma tumor (HP:0100723) | 2.32841410 |
| 88 | Recurrent otitis media (HP:0000403) | 2.32658028 |
| 89 | Xerostomia (HP:0000217) | 2.32271424 |
| 90 | Seborrheic dermatitis (HP:0001051) | 2.31927149 |
| 91 | Arthralgia (HP:0002829) | 2.29752706 |
| 92 | Gastrointestinal inflammation (HP:0004386) | 2.29528575 |
| 93 | Increased circulating renin level (HP:0000848) | 2.29522254 |
| 94 | Acute hepatic failure (HP:0006554) | 2.28428041 |
| 95 | Poor speech (HP:0002465) | 2.27688686 |
| 96 | Premature skin wrinkling (HP:0100678) | 2.26265320 |
| 97 | Pulmonary embolism (HP:0002204) | 2.25766731 |
| 98 | Myositis (HP:0100614) | 2.24674500 |
| 99 | Abnormality of T cell physiology (HP:0011840) | 2.23744933 |
| 100 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.22708957 |
| 101 | Chronic sinusitis (HP:0011109) | 2.20957927 |
| 102 | Hepatitis (HP:0012115) | 2.19599144 |
| 103 | Vasculitis (HP:0002633) | 2.17988868 |
| 104 | Chest pain (HP:0100749) | 2.16146372 |
| 105 | Partial agenesis of the corpus callosum (HP:0001338) | 2.15722328 |
| 106 | Sepsis (HP:0100806) | 2.13833885 |
| 107 | Meningitis (HP:0001287) | 2.12328366 |
| 108 | Fatigue (HP:0012378) | 2.11050844 |
| 109 | Eosinophilia (HP:0001880) | 2.10936678 |
| 110 | Bronchiectasis (HP:0002110) | 2.10745256 |
| 111 | Hemoptysis (HP:0002105) | 2.10340065 |
| 112 | Akinesia (HP:0002304) | 2.10094505 |
| 113 | Dysmetria (HP:0001310) | 2.08857172 |
| 114 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.08168351 |
| 115 | Hammertoe (HP:0001765) | 2.07499244 |
| 116 | Hypertensive crisis (HP:0100735) | 2.07299735 |
| 117 | Increased IgE level (HP:0003212) | 2.07172124 |
| 118 | Split hand (HP:0001171) | 2.06968815 |
| 119 | Sparse scalp hair (HP:0002209) | 2.05982607 |
| 120 | Abnormality of eosinophils (HP:0001879) | 2.05829869 |
| 121 | Entropion (HP:0000621) | 2.05523144 |
| 122 | Amaurosis fugax (HP:0100576) | 2.03111433 |
| 123 | Restrictive lung disease (HP:0002091) | 2.02919349 |
| 124 | Granulocytopenia (HP:0001913) | 2.02425959 |
| 125 | Anomalous pulmonary venous return (HP:0010772) | 2.01867791 |
| 126 | Spastic paraparesis (HP:0002313) | 2.00844827 |
| 127 | J-shaped sella turcica (HP:0002680) | 1.99313115 |
| 128 | Pulmonary infiltrates (HP:0002113) | 1.99064351 |
| 129 | Thoracolumbar scoliosis (HP:0002944) | 1.98267114 |
| 130 | Neutropenia (HP:0001875) | 1.98081382 |
| 131 | Abnormality of male internal genitalia (HP:0000022) | 1.95590967 |
| 132 | Skin ulcer (HP:0200042) | 1.93850920 |
| 133 | Abnormality of the lumbar spine (HP:0100712) | 1.93310652 |
| 134 | Joint swelling (HP:0001386) | 1.92366093 |
| 135 | Severe combined immunodeficiency (HP:0004430) | 1.91283767 |
| 136 | Abnormality of glycolysis (HP:0004366) | 1.91104727 |
| 137 | Increased serum pyruvate (HP:0003542) | 1.91104727 |
| 138 | Dry hair (HP:0011359) | 1.91039841 |
| 139 | Limb dystonia (HP:0002451) | 1.88643508 |
| 140 | Insomnia (HP:0100785) | 1.87238933 |
| 141 | Submucous cleft hard palate (HP:0000176) | 1.85908060 |
| 142 | Pulmonary fibrosis (HP:0002206) | 1.85517001 |
| 143 | Abnormality of macrophages (HP:0004311) | 1.85198742 |
| 144 | Anteriorly placed anus (HP:0001545) | 1.84573799 |
| 145 | Abnormality of the pleura (HP:0002103) | 1.83931807 |
| 146 | Orchitis (HP:0100796) | 1.83208567 |
| 147 | Hyperlipoproteinemia (HP:0010980) | 1.83052912 |
| 148 | Leukocytosis (HP:0001974) | 1.82674521 |
| 149 | Lower limb muscle weakness (HP:0007340) | 1.82346155 |
| 150 | Chronic diarrhea (HP:0002028) | 1.82260538 |
| 151 | Abnormality of the fingertips (HP:0001211) | 1.81762042 |
| 152 | Arterial thrombosis (HP:0004420) | 1.81672228 |
| 153 | Hypergammaglobulinemia (HP:0010702) | 1.81430659 |
| 154 | Encephalitis (HP:0002383) | 1.80808301 |
| 155 | Combined immunodeficiency (HP:0005387) | 1.80454349 |
| 156 | Autoimmune thrombocytopenia (HP:0001973) | 1.79896746 |
| 157 | Generalized hypotonia (HP:0001290) | 1.79313859 |
| 158 | Spondylolisthesis (HP:0003302) | 1.78287884 |
| 159 | Gangrene (HP:0100758) | 1.76096068 |
| 160 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 1.74174000 |
| 161 | Acrocyanosis (HP:0001063) | 1.73778803 |
| 162 | Prostate neoplasm (HP:0100787) | 1.72120129 |
| 163 | Ureteral obstruction (HP:0006000) | 1.71747737 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STK39 | 4.93616421 |
| 2 | EPHB1 | 4.71678361 |
| 3 | TNIK | 4.20920521 |
| 4 | RIPK4 | 4.20359711 |
| 5 | EIF2AK3 | 4.08273337 |
| 6 | TXK | 3.68519371 |
| 7 | CLK1 | 3.49769898 |
| 8 | MAP4K1 | 3.41882251 |
| 9 | CASK | 3.10146720 |
| 10 | NEK9 | 3.05700550 |
| 11 | SMG1 | 2.86370087 |
| 12 | OXSR1 | 2.42706619 |
| 13 | MAPKAPK5 | 2.24031655 |
| 14 | CCNB1 | 2.14869649 |
| 15 | PKN1 | 2.11578556 |
| 16 | IRAK1 | 1.90579961 |
| 17 | STK24 | 1.90296422 |
| 18 | BMPR2 | 1.89374720 |
| 19 | PASK | 1.89100849 |
| 20 | IRAK4 | 1.80633653 |
| 21 | VRK1 | 1.79591349 |
| 22 | MST4 | 1.76510045 |
| 23 | ZAK | 1.73229951 |
| 24 | STK10 | 1.70895255 |
| 25 | ITK | 1.69038505 |
| 26 | TBK1 | 1.66414523 |
| 27 | EEF2K | 1.66314293 |
| 28 | FGFR4 | 1.66269977 |
| 29 | MAPK13 | 1.63856608 |
| 30 | TAF1 | 1.61869901 |
| 31 | PRKCQ | 1.61042975 |
| 32 | JAK3 | 1.53057184 |
| 33 | UHMK1 | 1.46796103 |
| 34 | TAOK3 | 1.38446075 |
| 35 | TYRO3 | 1.35287429 |
| 36 | EPHA3 | 1.30901124 |
| 37 | ROCK2 | 1.30897923 |
| 38 | LCK | 1.30580894 |
| 39 | MAP3K10 | 1.27986529 |
| 40 | WNK4 | 1.25904700 |
| 41 | MAPK11 | 1.25555057 |
| 42 | FES | 1.25366734 |
| 43 | BTK | 1.24407808 |
| 44 | JAK1 | 1.21259194 |
| 45 | FGR | 1.19246437 |
| 46 | FGFR3 | 1.18161945 |
| 47 | NLK | 1.18005089 |
| 48 | BUB1 | 1.16014956 |
| 49 | ZAP70 | 1.10226073 |
| 50 | PIM1 | 1.08427881 |
| 51 | IKBKE | 1.04027436 |
| 52 | CDC7 | 1.02715282 |
| 53 | SGK494 | 1.02626362 |
| 54 | SGK223 | 1.02626362 |
| 55 | MET | 1.01263621 |
| 56 | CSK | 1.00101221 |
| 57 | DYRK2 | 0.99959679 |
| 58 | RPS6KA5 | 0.97758681 |
| 59 | TESK2 | 0.94148874 |
| 60 | NME2 | 0.91814364 |
| 61 | PRKCH | 0.91594813 |
| 62 | MAP3K13 | 0.89273702 |
| 63 | EIF2AK1 | 0.86959408 |
| 64 | STK38L | 0.86872388 |
| 65 | IRAK2 | 0.86681010 |
| 66 | FGFR2 | 0.86046404 |
| 67 | DAPK3 | 0.85372035 |
| 68 | ALK | 0.82611957 |
| 69 | GRK6 | 0.80335659 |
| 70 | CHUK | 0.79997089 |
| 71 | MAP3K7 | 0.79452534 |
| 72 | VRK2 | 0.79053313 |
| 73 | NTRK1 | 0.77023740 |
| 74 | FYN | 0.76743636 |
| 75 | EIF2AK2 | 0.76213351 |
| 76 | LRRK2 | 0.76209102 |
| 77 | IRAK3 | 0.75424199 |
| 78 | CSNK1G3 | 0.74673938 |
| 79 | MAP3K14 | 0.73875503 |
| 80 | PRPF4B | 0.71066993 |
| 81 | SIK3 | 0.69829793 |
| 82 | SYK | 0.69662496 |
| 83 | HIPK2 | 0.69299824 |
| 84 | PRKCI | 0.68736287 |
| 85 | MATK | 0.68387045 |
| 86 | HCK | 0.67581513 |
| 87 | WNK1 | 0.66105462 |
| 88 | PAK3 | 0.65215555 |
| 89 | NEK6 | 0.63529471 |
| 90 | CDK4 | 0.62997844 |
| 91 | MAP3K8 | 0.62874120 |
| 92 | DMPK | 0.62768077 |
| 93 | PAK6 | 0.62635951 |
| 94 | PIK3CG | 0.58930765 |
| 95 | CSNK1A1L | 0.58169367 |
| 96 | TYK2 | 0.57841889 |
| 97 | CSF1R | 0.57812570 |
| 98 | JAK2 | 0.57523440 |
| 99 | SIK1 | 0.56703619 |
| 100 | TRPM7 | 0.55851835 |
| 101 | SIK2 | 0.55077980 |
| 102 | BCR | 0.54421879 |
| 103 | TEC | 0.53908390 |
| 104 | PDGFRB | 0.53799079 |
| 105 | CSNK1G2 | 0.53739779 |
| 106 | CSNK1G1 | 0.53678983 |
| 107 | NEK1 | 0.53013470 |
| 108 | TLK1 | 0.52971402 |
| 109 | CDK12 | 0.52584676 |
| 110 | MAPK7 | 0.52397445 |
| 111 | CAMKK2 | 0.51873073 |
| 112 | BRD4 | 0.51503490 |
| 113 | RPS6KB2 | 0.51291039 |
| 114 | PAK2 | 0.49583795 |
| 115 | LYN | 0.49338932 |
| 116 | BLK | 0.49204263 |
| 117 | BMPR1B | 0.48013685 |
| 118 | CAMK2B | 0.46213648 |
| 119 | IKBKB | 0.46092157 |
| 120 | PDK1 | 0.46030427 |
| 121 | GSK3A | 0.45797720 |
| 122 | INSR | 0.44679859 |
| 123 | PRKD1 | 0.44016403 |
| 124 | CDK5 | 0.42769315 |
| 125 | MAP3K5 | 0.42236324 |
| 126 | MAPK12 | 0.41473019 |
| 127 | ATR | 0.41023904 |
| 128 | NME1 | 0.40897688 |
| 129 | MAP3K6 | 0.40644676 |
| 130 | MAPK4 | 0.40224340 |
| 131 | MELK | 0.39793613 |
| 132 | MARK3 | 0.39436912 |
| 133 | CSNK1D | 0.39335497 |
| 134 | MAPKAPK2 | 0.39261620 |
| 135 | CAMKK1 | 0.37705111 |
| 136 | PRKCD | 0.36738852 |
| 137 | BMX | 0.34952006 |
| 138 | BCKDK | 0.34353325 |
| 139 | CDC42BPA | 0.34236178 |
| 140 | STK16 | 0.33761549 |
| 141 | STK3 | 0.33232745 |
| 142 | CHEK1 | 0.32829468 |
| 143 | NUAK1 | 0.32696620 |
| 144 | ERN1 | 0.32651672 |
| 145 | AURKB | 0.31746046 |
| 146 | DAPK1 | 0.31251494 |
| 147 | RET | 0.30789325 |
| 148 | MAP3K9 | 0.29988622 |
| 149 | TTN | 0.29031169 |
| 150 | AURKA | 0.28828367 |
| 151 | MUSK | 0.28637460 |
| 152 | KIT | 0.28005331 |
| 153 | CDK9 | 0.27476640 |
| 154 | PRKCE | 0.27423186 |
| 155 | STK4 | 0.27127243 |
| 156 | CHEK2 | 0.27083123 |
| 157 | CDK19 | 0.26743683 |
| 158 | PIM2 | 0.25800728 |
| 159 | TAOK2 | 0.25692841 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 5.52408860 |
| 2 | Steroid biosynthesis_Homo sapiens_hsa00100 | 5.00544362 |
| 3 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.60880209 |
| 4 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 3.46931971 |
| 5 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 3.32647370 |
| 6 | Fatty acid elongation_Homo sapiens_hsa00062 | 3.02788559 |
| 7 | Ether lipid metabolism_Homo sapiens_hsa00565 | 2.93305671 |
| 8 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.71112865 |
| 9 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.70474821 |
| 10 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.39716986 |
| 11 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 2.11658567 |
| 12 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.10797743 |
| 13 | Allograft rejection_Homo sapiens_hsa05330 | 1.99321186 |
| 14 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.94311947 |
| 15 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.87768329 |
| 16 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.87275226 |
| 17 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.78693639 |
| 18 | Influenza A_Homo sapiens_hsa05164 | 1.76757676 |
| 19 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.59111178 |
| 20 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.53138958 |
| 21 | Alcoholism_Homo sapiens_hsa05034 | 1.49717434 |
| 22 | Asthma_Homo sapiens_hsa05310 | 1.46244270 |
| 23 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.44997101 |
| 24 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.42077808 |
| 25 | ABC transporters_Homo sapiens_hsa02010 | 1.35942268 |
| 26 | Axon guidance_Homo sapiens_hsa04360 | 1.33706033 |
| 27 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.31793848 |
| 28 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.30866245 |
| 29 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.30607026 |
| 30 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.28980688 |
| 31 | Histidine metabolism_Homo sapiens_hsa00340 | 1.28939959 |
| 32 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.24999142 |
| 33 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.23866490 |
| 34 | Apoptosis_Homo sapiens_hsa04210 | 1.22753010 |
| 35 | Measles_Homo sapiens_hsa05162 | 1.20196524 |
| 36 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.17925502 |
| 37 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.16559093 |
| 38 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.15361632 |
| 39 | Platelet activation_Homo sapiens_hsa04611 | 1.14395541 |
| 40 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.08926909 |
| 41 | Hepatitis B_Homo sapiens_hsa05161 | 1.07307098 |
| 42 | DNA replication_Homo sapiens_hsa03030 | 1.02939670 |
| 43 | Tuberculosis_Homo sapiens_hsa05152 | 1.02137396 |
| 44 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.00774929 |
| 45 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.00514484 |
| 46 | Long-term depression_Homo sapiens_hsa04730 | 0.99670753 |
| 47 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.99049292 |
| 48 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.98676467 |
| 49 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.96522663 |
| 50 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.94824201 |
| 51 | HTLV-I infection_Homo sapiens_hsa05166 | 0.92346564 |
| 52 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.87511645 |
| 53 | Leishmaniasis_Homo sapiens_hsa05140 | 0.85945551 |
| 54 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.85904778 |
| 55 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.83635102 |
| 56 | Proteasome_Homo sapiens_hsa03050 | 0.81700450 |
| 57 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.81547788 |
| 58 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.81427005 |
| 59 | Homologous recombination_Homo sapiens_hsa03440 | 0.80254679 |
| 60 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.80248428 |
| 61 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.78289167 |
| 62 | Mismatch repair_Homo sapiens_hsa03430 | 0.78222492 |
| 63 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.77702263 |
| 64 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.75652984 |
| 65 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.75154697 |
| 66 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.74762707 |
| 67 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.73148445 |
| 68 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.72787198 |
| 69 | Endocytosis_Homo sapiens_hsa04144 | 0.72620212 |
| 70 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.72106689 |
| 71 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.72031930 |
| 72 | Ribosome_Homo sapiens_hsa03010 | 0.68101662 |
| 73 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.66453352 |
| 74 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.65966686 |
| 75 | Shigellosis_Homo sapiens_hsa05131 | 0.65593381 |
| 76 | Lysosome_Homo sapiens_hsa04142 | 0.65439235 |
| 77 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.64038698 |
| 78 | Viral myocarditis_Homo sapiens_hsa05416 | 0.63521562 |
| 79 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.63130839 |
| 80 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.62891206 |
| 81 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.62840782 |
| 82 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.62619054 |
| 83 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.62581624 |
| 84 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.62096585 |
| 85 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.62087379 |
| 86 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.60960774 |
| 87 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.59704071 |
| 88 | Malaria_Homo sapiens_hsa05144 | 0.58248067 |
| 89 | RNA degradation_Homo sapiens_hsa03018 | 0.57006862 |
| 90 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.56432180 |
| 91 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.56244555 |
| 92 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.56196390 |
| 93 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.56064518 |
| 94 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.55516615 |
| 95 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.55207008 |
| 96 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.54252625 |
| 97 | Pertussis_Homo sapiens_hsa05133 | 0.50668482 |
| 98 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.48037510 |
| 99 | Spliceosome_Homo sapiens_hsa03040 | 0.47797576 |
| 100 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.47275970 |
| 101 | Base excision repair_Homo sapiens_hsa03410 | 0.45962471 |
| 102 | Hepatitis C_Homo sapiens_hsa05160 | 0.45958333 |
| 103 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.45854371 |
| 104 | Renin secretion_Homo sapiens_hsa04924 | 0.45665143 |
| 105 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.45505338 |
| 106 | Gap junction_Homo sapiens_hsa04540 | 0.45123833 |
| 107 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.44167976 |
| 108 | Colorectal cancer_Homo sapiens_hsa05210 | 0.44062178 |
| 109 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.43582092 |
| 110 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.43519158 |
| 111 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.43380596 |
| 112 | Salmonella infection_Homo sapiens_hsa05132 | 0.42867442 |
| 113 | Phagosome_Homo sapiens_hsa04145 | 0.42725260 |
| 114 | Cell cycle_Homo sapiens_hsa04110 | 0.42681410 |
| 115 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.41680457 |
| 116 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.41065571 |
| 117 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.40827511 |
| 118 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.40312644 |
| 119 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.39347470 |
| 120 | Morphine addiction_Homo sapiens_hsa05032 | 0.39317967 |
| 121 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.38855933 |
| 122 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.38581410 |
| 123 | Salivary secretion_Homo sapiens_hsa04970 | 0.38262017 |
| 124 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.37357134 |
| 125 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.36669481 |
| 126 | Long-term potentiation_Homo sapiens_hsa04720 | 0.36601410 |
| 127 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.35943184 |
| 128 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.35253229 |
| 129 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.35237798 |
| 130 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.34096258 |
| 131 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.31802093 |
| 132 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.31225073 |
| 133 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.30693943 |
| 134 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.28938183 |
| 135 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.28564835 |
| 136 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.27790372 |
| 137 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.27526669 |
| 138 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.26149348 |
| 139 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.25663471 |
| 140 | RNA transport_Homo sapiens_hsa03013 | 0.25579045 |
| 141 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.24802496 |
| 142 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.24523539 |
| 143 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.24084307 |
| 144 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.23036082 |
| 145 | Prostate cancer_Homo sapiens_hsa05215 | 0.22424273 |
| 146 | Endometrial cancer_Homo sapiens_hsa05213 | 0.22198572 |
| 147 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.20818505 |
| 148 | Legionellosis_Homo sapiens_hsa05134 | 0.20730535 |
| 149 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.20712439 |
| 150 | Protein export_Homo sapiens_hsa03060 | 0.18993373 |
| 151 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.17804634 |
| 152 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.14063913 |
| 153 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.13896595 |
| 154 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.13746838 |
| 155 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.10452557 |
| 156 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.09502789 |
| 157 | RNA polymerase_Homo sapiens_hsa03020 | 0.08816496 |
| 158 | Carbon metabolism_Homo sapiens_hsa01200 | 0.08430584 |

